Chronic cough, defined as a cough persisting for more than eight weeks, presents a common yet challenging condition for clinicians. It can significantly affect patients' quality of life and often remains elusive in etiology. This article aims to provide a comprehensive approach to diagnosing and treating chronic cough.
The most common causes of chronic cough in adults include upper airway cough syndrome, gastroesophageal reflux disease, and asthma. However, the etiology can often be multifactorial, necessitating a thorough clinical evaluation. A detailed history and physical examination are the cornerstones of the diagnostic process. The use of validated questionnaires like the Leicester Cough Questionnaire can aid in quantifying the impact of the cough and monitoring treatment response.
Diagnostic testing should be guided by the clinical suspicion. Chest radiographs and spirometry are often the initial investigations. If these are inconclusive, further testing such as high-resolution computed tomography, bronchoscopy, or esophageal pH monitoring may be warranted. It is crucial to remember that negative tests do not exclude a diagnosis, and empirical treatment trials may be necessary.
Treatment of chronic cough should be etiology-specific. Pharmacological options include inhaled corticosteroids, proton pump inhibitors, or antihistamines, depending on the underlying cause. Non-pharmacological interventions such as cough suppression techniques and behavioral therapy can be beneficial. Refractory cases may require referral to specialist cough clinics.
In conclusion, chronic cough presents a diagnostic and therapeutic challenge for clinicians. A systematic and comprehensive approach to evaluation, guided by clinical suspicion, can aid in uncovering the underlying etiology. Tailored treatment strategies, encompassing both pharmacological and non-pharmacological interventions, can improve patient outcomes and quality of life.
1.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
2.
Glioblastoma treatment breakthrough shows promise
3.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
1.
The Latest Research on Wiskott Aldrich Syndrome
2.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
3.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
4.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
5.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation